{"code":"C9073","short_description":"Brexucabtagene autoleucel ca","long_description":"Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose","status":"deleted","section":"C-codes: Outpatient PPS","category":"Outpatient PPS","effective_date":"2021-04-01","termination_date":"2021-03-31","replacement_code":"","opps_status_indicator":"","opps_status_label":null,"opps_apc":"","fee_schedules":[],"mue":[],"drug_classes":[],"ndc_crosswalk":[],"utilization":[],"urls":{"self_html":"https:\/\/hcpcslookup.com\/codes\/c9073","self_json":"https:\/\/hcpcslookup.com\/api\/codes\/C9073.json"}}